Literature DB >> 12689941

The role of autocrine FGF-2 in the distinctive bone marrow fibrosis of hairy-cell leukemia (HCL).

Khalil A Aziz1, Kathleen J Till, Haijuan Chen, Joseph R Slupsky, Fiona Campbell, John C Cawley, Mirko Zuzel.   

Abstract

Bone marrow (BM) fibrosis is a central diagnostic and pathogenetic feature of hairy-cell leukemia (HCL). It is known that fibronectin (FN) produced and assembled by the malignant hairy cells (HCs) themselves is a major component of this fibrosis. It is also known that FN production is greatly enhanced by adhesion of HCs to hyaluronan (HA) via CD44. The aim of the present study was to establish the roles of fibrogenic autocrine cytokines (fibroblast growth factor-2 [FGF-2] and transforming growth factor beta [TGFbeta]) and of different isoforms of CD44 in this FN production. We show that HC adhesion to HA stimulates FGF-2, but not TGFbeta, production and that HCs possess FGF-2 receptor. In a range of experiments, FN production was greatly reduced by blocking FGF-2 but not TGFbeta. Moreover FN, but not FGF-2, secretion was blocked by down-regulation of the v3 isoform of CD44 and by addition of heparitinase. These results show that autocrine FGF-2 secreted by HCs is the principal cytokine responsible for FN production by these cells when cultured on HA. The central role of FGF-2 in the pathogenesis of the BM fibrosis of HCL was supported by our immunohistochemical demonstration of large amounts of this cytokine in fibrotic BM but not in HCL spleen where there is no fibrosis. As regards CD44 isoforms, the present work demonstrates that CD44v3 is essential for providing the heparan sulfate necessary for HC stimulation by FGF-2, whereas the signal for production of the cytokine was provided by HA binding to CD44H, the standard hematopoietic form of the molecule.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12689941     DOI: 10.1182/blood-2002-12-3737

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Hairy cell leukemia.

Authors:  Ronan Swords; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders.

Authors:  Piers A Blombery; Stephen Q Wong; Chelsee A Hewitt; Alexander Dobrovic; Ellen L Maxwell; Surender Juneja; George Grigoriadis; David A Westerman
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

Review 3.  The microenvironment in hairy cell leukemia: pathways and potential therapeutic targets.

Authors:  Jan A Burger; Mariela Sivina; Farhad Ravandi
Journal:  Leuk Lymphoma       Date:  2011-03-25

4.  Genome-wide promoter methylation of hairy cell leukemia.

Authors:  Alberto J Arribas; Andrea Rinaldi; Giorgia Chiodin; Ivo Kwee; Afua Adjeiwaa Mensah; Luciano Cascione; Davide Rossi; Meena Kanduri; Richard Rosenquist; Emanuele Zucca; Peter W Johnson; Gianluca Gaidano; Christopher C Oakes; Francesco Bertoni; Francesco Forconi
Journal:  Blood Adv       Date:  2019-02-12

Review 5.  Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.

Authors:  Jérôme Paillassa; Elsa Maitre; Xavier Troussard
Journal:  Curr Oncol Rep       Date:  2022-04-11       Impact factor: 5.945

Review 6.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

7.  TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.

Authors:  Medhat Shehata; Josef D Schwarzmeier; Martin Hilgarth; Rainer Hubmann; Markus Duechler; Heinz Gisslinger
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 8.  Cancer associated fibroblasts in hematological malignancies.

Authors:  Lizzia Raffaghello; Angelo Vacca; Vito Pistoia; Domenico Ribatti
Journal:  Oncotarget       Date:  2015-02-20

9.  Antifungal, anti-inflammatory and cytotoxicity activities of three varieties of labisia pumila benth: from microwave obtained extracts.

Authors:  Ehsan Karimi; Hawa Z E Jaafar; Syahida Ahmad
Journal:  BMC Complement Altern Med       Date:  2013-01-24       Impact factor: 3.659

10.  Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors.

Authors:  Katia Basso; Arcangelo Liso; Enrico Tiacci; Roberta Benedetti; Alessandro Pulsoni; Robin Foa; Francesco Di Raimondo; Achille Ambrosetti; Andrea Califano; Ulf Klein; Riccardo Dalla Favera; Brunangelo Falini
Journal:  J Exp Med       Date:  2004-01-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.